Project Grant HT94252410346
Award Date
7/1/24
Completion Date
6/30/27
Dollars Obligated
$785K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Newark, NJ 07107, USA
Similar Awards
The Defense Health Agency awarded Rutgers, The State University of New Jersey a $942,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support targeted chemotherapeutic and immunotherapeutic research for drug-resistant ovarian cancer. The three-year award beginning April 1, 2023 will fund Rutgers Biomedical and Health Sciences' investigation into medical solutions for this treatment-resistant form of ovarian cancer through innovative research...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $649,000 Project Grant to Rutgers, The State University of New Jersey to conduct research aimed at "Characterizing the Oncogenic Transcriptional Activation During the Malignant Transformation of NF1 Nerve Sheath Tumors." The 3-year award, which commenced on August 1, 2025, supports advanced biomedical research to transform healthcare for military service members, veterans, and the...
This federal Project Grant award of $2,028,000.00, awarded on April 1, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research aimed at identifying epigenetically driven vulnerabilities in metastatic castration-resistant prostate cancer. The award was granted to the Icahn School of Medicine at Mount Sinai, a prominent academic medical center and research institution in New York City. Through this...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $768,420.00 to Rutgers, The State University of New Jersey's Cancer Institute to conduct research on rewiring very long chain fatty acid metabolism in pancreatic tumor-associated macrophages. The goal is to overcome resistance to KRAS-targeted therapy in pancreatic cancer. The award period runs from July 1, 2025 to June 30, 2028. The research aims to...
The Defense Health Agency awarded Rutgers, The State University a $471,000 project grant under the Military Medical Research and Development program (CFDA 12.420) to develop new therapeutic strategies for chemo brain in ovarian cancer survivors. The grant period runs from July 1, 2023 through June 30, 2027 in New Brunswick, New Jersey. Through its Research Financial Services division, Rutgers will leverage its expertise in bioengineering and disease research to investigate medical solutions...
This federal Project Grant award for $465,935.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is funding research conducted by the University of Wisconsin - Madison to combine PSMA and BRD4 disruption approaches to overcome resistance in advanced prostate cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical solutions to critical...
The federal Project Grant award of $946,873.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research to investigate the genetic risk of prostate cancer in self-identified Black veterans. The award was granted to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a prominent private research university and academic medical center in Philadelphia. The research...
The federal Block Grant award of $824,250 was provided by the Defense Health Agency to Rutgers, The State University of New Jersey, to support the Lung Cancer Research Program. This award, under the Military Medical Research and Development program (CFDA 12.420), will fund innovative biomedical research projects at Rutgers focused on improving health outcomes for military service members, veterans, and the broader public. Rutgers, leveraging its expertise in medicine, nursing, public health, and...
Rutgers The State University Of New Jersey, doing business as Rbhs-School Of Nursing, was awarded a $785,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund development of new therapeutic strategies for chemo brain in ovarian cancer survivors from July 1, 2023 through June 30, 2027. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform...
This federal Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The $988,740 award, effective June 15, 2025 through June 14, 2028, will fund research by Weill Medical College of Cornell University to develop "Genomically Informed Morphological Stromal Signatures to Predict Lethal...